Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

993
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
993
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

944
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
944
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suicide and coronial problems.

The Medico-legal journal·2022
Same author

Obstetrics and gynaecology and the law.

The Medico-legal journal·2022
Same author

Forensic Science Regulator: The Forensic Science Regulator Act 2021.

The Medico-legal journal·2022
Same author

A new wrinkle in Montgomery? The surgeon faces the unexpected.

The Medico-legal journal·2022
Same author

Assisted dying.

The Medico-legal journal·2022
Same author

Andrew Malkinson: A miscarriage of justice?

Medicine, science, and the law·2021
Same journal

Fatal colloid cyst of the foramen of Monro: A forensic case report.

The Medico-legal journal·2026
Same journal

Silent but fatal: Sudden death from asymptomatic severe aortic stenosis.

The Medico-legal journal·2026
Same journal

Fatal fall causing isolated thoracic impalement with bi-ventricular cardiac rupture.

The Medico-legal journal·2026
Same journal

Marriage equality is not enough: The need for surrogacy-specific clinical guidance in Thailand.

The Medico-legal journal·2026
Same journal

Bradycardia and heart block due to lithium toxicity.

The Medico-legal journal·2026
Same journal

GERD-related microaspiration as a contaminant in breath alcohol testing: Case reports.

The Medico-legal journal·2026
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

2.3K

The NHS refuses treatment.

Alec Samuels

    The Medico-Legal Journal
    |February 2, 2019
    PubMed
    Summary
    This summary is machine-generated.

    This article examines the reasonableness of treatment refusal, considering legal duties, treatment effectiveness, and resource allocation. It explores treatment priorities, eligibility, and the economic benefits of preventative medicine.

    Keywords:
    Treatmentreasonsrefusalresourcesrights and duties

    More Related Videos

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    39.5K
    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
    08:20

    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

    Published on: August 11, 2015

    14.6K

    Related Experiment Videos

    Last Updated: Jan 30, 2026

    Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
    04:25

    Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

    Published on: November 8, 2024

    2.3K
    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    39.5K
    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
    08:20

    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

    Published on: August 11, 2015

    14.6K

    Area of Science:

    • Medical Ethics
    • Health Policy
    • Public Health

    Background:

    • Examines the complexities surrounding patient treatment refusal.
    • Considers the influence of statutory duties and National Institute for Health and Care Excellence (NICE) guidelines.
    • Evaluates the impact of resource availability on treatment decisions.

    Observation:

    • Investigates the criteria for determining reasonable treatment refusal.
    • Analyzes the prioritization of medical interventions.
    • Discusses eligibility criteria for accessing treatments.

    Findings:

    • Highlights the economic case for early intervention and preventative medicine.
    • Addresses ethical considerations, including human rights in healthcare.
    • Uses case examples to illustrate complex scenarios of treatment refusal.

    Implications:

    • Informs healthcare providers and policymakers on navigating treatment refusal ethically and legally.
    • Suggests strategies for optimizing resource allocation in healthcare.
    • Emphasizes the importance of balancing patient autonomy with public health considerations.